News of biotech VC's demise may be premature

05/16/2013 | Genetic Engineering & Biotechnology News

While venture capital investment in biotech has declined overall, investment in early-stage biosensor companies rose 152% and investment in biotech research rose 37% year-on-year during the first quarter of 2013, according to PricewaterhouseCoopers.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care